Drug General Information
Drug ID
D08QIR
Former ID
DIB004693
Drug Name
H2S-releasing latanoprost
Synonyms
ACS-67; H2S-releasing latanoprost (ocular disease); H2S-releasing latanoprost (ocular disease), CTG Pharma
Indication Ocular disease [ICD10:H00-H59] Investigative [543781]
Company
CTG Pharma Srl
Structure
Download
2D MOL

3D MOL

Canonical SMILES
c1c(=S)ssc1c1ccc(OC(=O)CCC/C=C\C[C@@H]2[C@H]([C@@H](C[C<br />@@H]2O)O)CC[C@H](CCc2ccccc2)O)cc1
Target and Pathway
Target(s) Prostaglandin F2-alpha receptor Target Info Modulator [543781]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
Reactome Prostanoid ligand receptors
G alpha (q) signalling events
WikiPathways Prostaglandin Synthesis and Regulation
GPCRs, Class A Rhodopsin-like
Gastrin-CREB signalling pathway via PKC and MAPK
Small Ligand GPCRs
GPCR ligand binding
GPCR downstream signaling
GPCRs, Other
References
Ref 543781(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 344).
Ref 543781(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 344).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.